Pakistan pharma industry opposes proposal to alter the drug pricing formula
Pakistan’s pharmaceutical manufacturing industry has expressed concern over a federal minister’s directives to amend the existing drug pricing mechanism, warning that sudden changes could cripple the industry, disrupt medicine supplies and undermine efforts to ensure the availability of affordable medicines. Industry officials said the existing Drug Pricing Policy, 2018 was endorsed by the Supreme Court and was developed by the government through a thorough process involving consultations with stakeholders, rather than by any individual or small group.